Sumitomo Pharma Co., Ltd. (DNPUF)
8.405
0.00 (0.00%)
USD |
OTCM |
Aug 24, 16:00
Sumitomo Pharma Shareholders Equity (Quarterly) : 2.514B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.514B |
| March 31, 2026 | 1.838B |
| December 31, 2025 | 1.843B |
| September 30, 2025 | 1.798B |
| June 30, 2025 | 1.220B |
| March 31, 2025 | 1.133B |
| December 31, 2024 | 1.057B |
| September 30, 2024 | 798.17M |
| June 30, 2024 | 999.98M |
| March 31, 2024 | 1.031B |
| December 31, 2023 | 2.437B |
| September 30, 2023 | 2.761B |
| June 30, 2023 | 2.885B |
| March 31, 2023 | 3.056B |
| December 31, 2022 | 4.814B |
| September 30, 2022 | 4.464B |
| June 30, 2022 | 4.954B |
| March 31, 2022 | 5.008B |
| December 31, 2021 | 5.217B |
| September 30, 2021 | 5.219B |
| June 30, 2021 | 5.172B |
| March 31, 2021 | 5.254B |
| December 31, 2020 | 5.300B |
| September 30, 2020 | 5.150B |
| June 30, 2020 | 5.015B |
| Date | Value |
|---|---|
| March 31, 2020 | 4.934B |
| December 31, 2019 | 4.784B |
| September 30, 2019 | 4.734B |
| June 30, 2019 | 4.543B |
| March 31, 2019 | 4.501B |
| December 31, 2018 | 4.539B |
| September 30, 2018 | 4.324B |
| June 30, 2018 | 4.223B |
| March 31, 2018 | |
| December 31, 2017 | 4.586B |
| September 30, 2017 | 4.407B |
| June 30, 2017 | 4.203B |
| March 31, 2017 | 4.134B |
| December 31, 2016 | 4.062B |
| September 30, 2016 | 4.136B |
| June 30, 2016 | 4.151B |
| March 31, 2016 | 3.972B |
| December 31, 2015 | 3.891B |
| September 30, 2015 | 3.804B |
| June 30, 2015 | 3.745B |
| March 31, 2015 | 3.761B |
| December 31, 2014 | 3.772B |
| September 30, 2014 | 3.829B |
| June 30, 2014 | 3.910B |
| March 31, 2014 | 3.870B |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 46.50B |
| Daiichi Sankyo Co., Ltd. | 10.48B |
| Eisai Co., Ltd. | 5.578B |
| Chugai Pharmaceutical Co., Ltd. | 12.48B |
| Santen Pharmaceutical Co., Ltd. | 1.847B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.198B |
| Total Liabilities (Quarterly) | 2.685B |
| Debt to Equity Ratio | 0.3932 |
| Current Ratio | 1.212 |
| Net Debt Paydown Yield | 5.27% |